There's still hope for stem cells with Okarma. 2-year-old girl gets windpipe made from stem cells
CHICAGO — A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.
Okarma will be starting with nothing but Geron IP and not even enough cash for the first year salaries. So, why give the IP away for peanuts and have 21% of a new company. Why not hire the people back and keep 100% of a new company. After all, 0=0 at the beginning in either case. And we shareholders spent $500,000,000 developing the IP. If these people aren't crooks, where are their brains?
A big pharma probably wants Imetelstat but they don't want the liability of stem cells with all the Bible thumpers and what happened to stem cell patents in the European union. When you get knocked down you get back up and try again.